AzTrials
AzTrials

Gestational DiabetesNCT04861324

Effects of a Lifestyle Intervention on Gestational Diabetes Management

A study testing Dietary Intervention in people with Gestational Diabetes and Type 2 Diabetes, run by University of Nevada, Las Vegas at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate the effects of nutrition education focusing on colorful fruit and vegetable intake with after-meal physical activity guidance on glycemic control and complications in women with gestational diabetes and pre-gestational diabetes. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
What is being tested?
Dietary Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
1 siteUnited States
Study dates
28 Apr 2021to 30 Jan 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • high risk for gestational diabetes
  • willing to make lifestyle changes
  • history of diabetes

Who cannot join

  • carrying more than one fetus
  • history of chronic conditions except diabetes and hypertension

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UNLV School of Medicine MFM clinic

    Las Vegas, Nevada, 89154

Other trials in United States

About this study

The purpose of this study is to investigate the effects of nutrition education focusing on colorful fruit and vegetable intake with after-meal physical activity guidance on glycemic control and complications in women with gestational diabetes and pre-gestational diabetes.

Read the detailed description

Diabetes (high blood sugar) developed during pregnancy can be harmful to the mother as it can lead to delivery complications because of a large baby and increases risks of type 2 diabetes and heart disease in the mother and baby in later life. Thus, pregnancy is a critical time during the human lifespan to make effective dietary changes that are safe for both mother and the fetus and reduce risks of developing diabetes and pregnancy complications. Women at risk for gestational diabetes will be randomly assigned to the standard care or the nutrition education group. Blood draws and other biomedical measures will be collected at baseline and at end of the study before delivery.

Medical subject headings
Diabetes, Gestational, Diabetes Mellitus, Type 2, Metabolic Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dietary InterventionBehavioural

    Increasing fruit and vegetable by two servings a day and at least 30 min a day of postprandial physical activity

Study groups in NCT04861324
Study groupRoleWhat they receive
Prenatal Care/Nutrition EducationNo interventionStandard prenatal care with primary care physician with USDA-based federal guidelines
Fruit/veggie + postprandial physical activityExperimentalNutrition education on increasing fruit and vegetable consumption and physical education on increasing postprandial physical activity for the duration from GDM diagnosis till delivery
Receives: Behavioral: Dietary Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maternal glycemic control

    Blood glycated hemoglobin

    Measured: 12 weeks

  2. Maternal gestational weight gain

    Body weight

    Measured: 12 weeks

  3. Maternal medication usage

    Glucose-lowering medications

    Measured: 12 weeks

  4. Maternal Lipids

    LDL-cholesterol and triglycerides

    Measured: 12 weeks

Secondary outcomes (2)
  1. Maternal inflammation

    Adipokines, C-reactive protein

    Measured: 12 weeks

  2. Maternal serum carotenoids

    Carotenoids indicating fruit and vegetable consumption

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Apr 2021
  2. Study start28 Apr 2021
  3. Primary completion31 Dec 2022
  4. Study completion30 Jan 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
45 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04861324
Sponsor's protocol ID
1610677
Status last verified
Feb 2023
First submitted
22 Apr 2021
Last updated
17 Feb 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Dietary Intervention in people with Gestational Diabetes and Type 2 Diabetes, run by University of Nevada, Las Vegas at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maternal glycemic control (time frame: 12 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in